secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2025-05-27T23:59:59+00:00
Accession:  0001077183-25-000109
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics shareholders approve 4.325M share increase to 2023 Equity Plan, all directors re-elected
--------------------------------------------------------------------------------

- Amendment to 2023 Equity Incentive Plan approved: +4.325M shares, 1-year minimum vesting, no liberal share recycling.
- All nine director nominees elected; votes ranged from 93.7% to 99.1% support (excluding broker non-votes).
- Advisory say-on-pay passed with 81.77% of votes cast; board adopted annual frequency for future votes.
- Ratification of Deloitte & Touche as auditor received 99.86% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718325000109/0001077183-25-000109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718325000109/neo-20250522.htm
  HTML page:      https://secwatch.observer/filing/0001077183-25-000109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer